Yi-Bin A. Chen, MD, Massachusetts General Hospital

Articles

Graft-vs-Host Disease Prophylaxis Clinical Trials

June 19th 2020

Special Transplant Situations

June 19th 2020

Risk Factors for Graft-vs-Host Disease

June 19th 2020

Overview of Graft-Vs-Host Disease

June 19th 2020

Members of the Transplant Team

June 19th 2020

Timing of Referral for Transplant

June 19th 2020

Clinical Trial Investigation: Where to Go From Here

June 11th 2020

The Future of GvHD: Promising Agents in Development

June 11th 2020

GvHD Management Recommendations

June 11th 2020

REACH2 Trial: Practical Implications and AE Management

June 11th 2020

Treatment for Steroid-Refractory GVHD: REACH2

June 11th 2020

When to Initiate Second-Line Therapy

June 11th 2020

Second-Line Therapy for GvHD

June 11th 2020

The Role of Steroids in GvHD Management

June 11th 2020

Multidisciplinary Treatment and Supportive Care

June 11th 2020

The Importance of Multidisciplinary Approach

June 11th 2020

Frontline Agents for GvHD

June 11th 2020

GVHD Grading and Staging

June 11th 2020

Risk Factors, Incidence & Typical Presentation of GvHD

June 11th 2020

The Nature of Acute and Chronic GvHD

June 11th 2020